GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Ajooni Biotech Ltd (NSE:AJOONI) » Definitions » Cash And Cash Equivalents

Ajooni Biotech (NSE:AJOONI) Cash And Cash Equivalents : ₹3.1 Mil (As of Mar. 2023)


View and export this data going back to 2018. Start your Free Trial

What is Ajooni Biotech Cash And Cash Equivalents?

Ajooni Biotech's quarterly cash and cash equivalents increased from Sep. 2022 (₹1.82 Mil) to Dec. 2022 (₹227.32 Mil) but then stayed the same from Dec. 2022 (₹227.32 Mil) to Mar. 2023 (₹3.09 Mil).

Ajooni Biotech's annual cash and cash equivalents declined from Mar. 2021 (₹2.44 Mil) to Mar. 2022 (₹0.57 Mil) but then increased from Mar. 2022 (₹0.57 Mil) to Mar. 2023 (₹3.09 Mil).


Ajooni Biotech Cash And Cash Equivalents Historical Data

The historical data trend for Ajooni Biotech's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ajooni Biotech Cash And Cash Equivalents Chart

Ajooni Biotech Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Cash And Cash Equivalents
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.31 1.24 2.44 0.57 3.09

Ajooni Biotech Quarterly Data
Mar15 Mar16 Mar17 Aug17 Mar18 Sep18 Mar19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23
Cash And Cash Equivalents Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.57 1.65 1.82 227.32 3.09

Ajooni Biotech Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.


Ajooni Biotech  (NSE:AJOONI) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.


Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.


Ajooni Biotech Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of Ajooni Biotech's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.


Ajooni Biotech (NSE:AJOONI) Business Description

Traded in Other Exchanges
N/A
Address
D-118, Industrial Area, Phase VII, Mohali, PB, IND, 160055
Ajooni Biotech Ltd is engaged in the production of animal feed. The company's products of cattle feed include Nurture Calf Starter, Winner 10ltr, Hiffer/Grower, Energy Plus, Eco- 5ltr, Milk Booster, & Buff Power, and its feed supplements include Autovita, Livtus, Caltus, Rumitus, and other products. It derives majority portion of the revenue from the manufacturing of cattle feed. The company operates only in India.

Ajooni Biotech (NSE:AJOONI) Headlines

No Headlines